We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$125B
AUM Growth
+$7.74B
(+6.6%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
32.47%
Holding
4,267
New
79
Increased
1,134
Reduced
2,614
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$80.1M |
| 2 |
Chevron
CVX
|
+$75.4M |
| 3 |
Robinhood
HOOD
|
+$52.2M |
| 4 |
Nutanix
NTNX
|
+$32.2M |
| 5 |
Datadog
DDOG
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$166M |
| 2 |
Apple
AAPL
|
+$150M |
| 3 |
NVIDIA
NVDA
|
+$148M |
| 4 |
HES
Hess
HES
|
+$72.3M |
| 5 |
ANSS
Ansys
ANSS
|
+$59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.89% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 9.45% |
| 5 | Healthcare | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
PCB Bancorp
PCB
$391M
| $330K | ﹤0.01% |
15,697
-359
| -2% | -$7.72K |
|
2777
Atea Pharmaceuticals
AVIR
$420M
| $329K | ﹤0.01% |
113,612
-5,808
| -5% | -$19.8K |
|
|
ONTF
2778
DELISTED
ON24
ONTF
| $329K | ﹤0.01% |
57,444
-2,083
| -3% | -$11.2K |
|
|
JBS
2779
JBS N.V.
JBS
$46.8B
| $328K | ﹤0.01% |
21,953
+8,025
| +58% | +$117K |
|
2780
Flotek Industries
FTK
$1.28B
| $327K | ﹤0.01% |
22,400
+770
| +4% | +$9.73K |
|
2781
Voyager Therapeutics
VYGR
$201M
| $327K | ﹤0.01% |
69,991
+1,704
| +2% | +$6.17K |
|
2782
Frequency Electronics
FEIM
$816M
| $326K | ﹤0.01% |
9,618
-258
| -3% | -$7.17K |
|
2783
BK Technologies
BKTI
$291M
| $326K | ﹤0.01% |
3,856
+615
| +19% | +$35.1K |
|
2784
Parke Bancorp
PKBK
$405M
| $321K | ﹤0.01% |
14,904
-1,065
| -7% | -$23.1K |
|
2785
Rocky Brands
RCKY
$369M
| $321K | ﹤0.01% |
10,771
-362
| -3% | -$9.72K |
|
2786
Prudential
PUK
$35.2B
| $320K | ﹤0.01% |
11,432
-935
| -8% | -$24.5K |
|
|
ONC
2787
BeOne Medicines Ltd
ONC
$39.4B
| $319K | ﹤0.01% |
937
-199
| -18% | -$60.4K |
|
2788
Puma Biotechnology
PBYI
$454M
| $319K | ﹤0.01% |
60,001
-610
| -1% | -$2.59K |
|
2789
Arq
ARQ
$89.3M
| $318K | ﹤0.01% |
44,437
-170
| -0.4% | -$1.12K |
|
2790
Oportun Financial
OPRT
$372M
| $318K | ﹤0.01% |
51,467
+2,817
| +6% | +$18.1K |
|
2791
Franklin Covey
FC
$246M
| $317K | ﹤0.01% |
16,343
-512
| -3% | -$10.1K |
|
2792
Grupo Cibest SA
CIB
$21.1B
| $317K | ﹤0.01% |
6,102
-3,347
| -35% | -$162K |
|
2793
Designer Brands
DBI
$333M
| $317K | ﹤0.01% |
89,422
+26,237
| +42% | +$90.5K |
|
2794
Utah Medical Products
UTMD
$225M
| $316K | ﹤0.01% |
5,019
-697
| -12% | -$41.2K |
|
2795
Enbridge
ENB
$112B
| $316K | ﹤0.01% |
6,261
-2,490
| -28% | -$117K |
|
|
REFI
2796
Chicago Atlantic Real Estate Finance
REFI
$261M
| $316K | ﹤0.01% |
24,697
-1,816
| -7% | -$24.9K |
|
|
MBCN
2797
DELISTED
Middlefield Banc Corp
MBCN
| $316K | ﹤0.01% |
10,523
-95
| -0.9% | -$2.86K |
|
2798
908 Devices
MASS
$364M
| $316K | ﹤0.01% |
36,028
-388
| -1% | -$2.58K |
|
2799
Satellogic
SATL
$849M
| $314K | ﹤0.01% |
95,703
-1,243
| -1% | -$4.38K |
|
2800
Fennec Pharmaceuticals
FENC
$402M
| $314K | ﹤0.01% |
33,522
-375
| -1% | -$3.25K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2025 Portfolio in Review
As of Q3 2025, RhumbLine Advisers held 4,267 positions worth $125B, up 6.6% from $117B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.2%. RhumbLine Advisers opened 79 new positions and exited 100, leaving the 4,267-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q3 2025 buy was The Marzetti Company: 64,390 shares worth $11.1M.
- RhumbLine Advisers added most to Applovin in Q3 2025, an estimated $80.1M increase.
- RhumbLine Advisers's biggest Q3 2025 reduction was Microsoft, cutting an estimated $166M.
- RhumbLine Advisers fully exited Hess in Q3 2025, selling an estimated $72.3M.
- RhumbLine Advisers's ten largest holdings make up 32% of its $125B portfolio in Q3 2025.
- RhumbLine Advisers opened 79 new positions and closed 100 in Q3 2025.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $125B.
Based on RhumbLine Advisers's 13F filing for Q3 2025, filed 6 Nov 2025.